Acceder

Publicaciones - ONCOLOGÍA CLÍNICA Y TRASLACIONAL

Cargando...
Martinez-Garcia, J; Boix, AP; Henarejos, PS; Lucas, MDJ; Saura, AS; Luengo, M; Vicente, RC; Ortiz, MJM; Balsalobre, J; Barrio, PDLMD; Garre, EG; Garcia, E; Marin, G; Torralba, EG; de la Pena, FA; Collado, D; Lopez, A; Quiros, T; Sanchez, DA; Romero, JLA. Trastuzumab emtansine in HER2-positive metastatic breast cancer after pertuzumab and trastuzumab: TDM1RM Study. ANNALS OF ONCOLOGY. 2020; 31:S358-S358. 10.1016/j.annonc.2020.08.393
AÑO: 2020; IF: 32.976
Lluch A, Barrios CH, Torrecillas L, Ruiz-Borrego M, Bines J, Segalla J, Guerrero-Zotano A, Garcia-Saenz JA, Torres R, de la Haba J, Garcia-Martinez E, Gomez HL, Llombart A, Bofill JS, Baena-Canada JM, Barnadas A, Calvo L, Perez-Michel L, Ramos M, Fernandez I, Rodriguez-Lescure A, Cardenas J, Vinholes J, Martinez de Duenas E, Godes MJ, Segui MA, Anton A, Lopez-Alvarez P, Moncayo J, Amorim G, Villar E, Reyes S, Sampaio C, Cardemil B, Escudero MJ, Bezares S, Carrasco E, Martin M; GEICAM Spanish Breast Cancer Group; CIBOMA (Iberoamerican Coalition for Research in Breast Oncology); LACOG (Latin American Cooperative Oncology Group). Phase III Trial of Adjuvant Capecitabine After Standard Neo-/Adjuvant Chemotherapy in Patients With Early Triple-Negative Breast Cancer (GEICAM/2003-11_CIBOMA/2004-01). J Clin Oncol. 2020 Jan 20;38(3):203-213. doi: 10.1200/JCO.19.00904. Epub 2019 Dec 5. Erratum In: J Clin Oncol. 2020 Mar 10;38(8):847. PubMed PMID: 31804894; PubMed Central PMCID: PMC6968797.
AÑO: 2020; IF: 44.544
31804894
Alvarez-Lopez, I; Gonzalez, E; Manso, LM; Alonso, JL; Cruz-Hernandez, JJ; Ballerini, VC; Gallegos, I; Varela, MQ; Illaramendi, JJ; Vicente, E; Garcia, AIB; de la Pena, FA; Perello, A; Vidal, J; Cussac, AL. Role of early circulating tumour cell (CTC) monitoring for prediction of clinical outcome in patients with HER-2 negative metastatic breast cancer receiving first-line treatment with bevacizumab and paclitaxel. ANNALS OF ONCOLOGY. 2020; 31:S29-S29. 10.1016/j.annonc.2020.03.173
AÑO: 2020; IF: 32.976
Ciruelos EM, Diaz MN, Isla MD, Lopez R, Bernabe R, Gonzalez E, Cirauqui B, Coves J, Morales S, Arcediano A, Barneto I, Cerezuela P, Illarramendi JJ, Morales C, Ponce S. Patient preference for oral chemotherapy in the treatment of metastatic breast and lung cancer. Eur J Cancer Care (Engl). 2019 Nov;28(6):e13164. doi: 10.1111/ecc.13164. Epub 2019 Sep 30. PubMed PMID: 31571304.
AÑO: 2019; IF: 2.161
31571304
Bachelot T, Ciruelos E, Schneeweiss A, Puglisi F, Peretz-Yablonski T, Bondarenko I, Paluch-Shimon S, Wardley A, Merot JL, du Toit Y, Easton V, Lindegger N, Miles D; PERUSE investigators. Preliminary safety and efficacy of first-line pertuzumab combined with trastuzumab and taxane therapy for HER2-positive locally recurrent or metastatic breast cancer (PERUSE). Ann Oncol. 2019 May 1;30(5):766-773. doi: 10.1093/annonc/mdz061. PubMed PMID: 30796821.
AÑO: 2019; IF: 18.274
30796821
< AnteriorSiguiente >
IMIB-Arrixaca

Instituto de Investigación Sanitaria Acreditado

ISCII

ONCOLOGÍA CLÍNICA Y TRASLACIONAL